Can Restaging Transurethral Resection of T1 Bladder Cancer Select Patients for Immediate Cystectomy?

Journal of Urology

Volumn 177, Issue 1, 2007, Pages 75-79

  Herr, Harry W ^a   Donat, S Machele ^a   Dalbagni, Guido ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

bladder; bladder neoplasms; disease progression; reoperation

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BCG VACCINATION; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 33845346443     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.070     Document Type: Article

References (20)

1. Andius P., and Holmang S. Bacillus Calmette-Guerin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int 93 (2003) 980
2. Shahin O., Thalman G.N., Rentsch C., Mazzucchelli L., and Studer U.E. A retrospective analysis of 153 patients treated with or without intravesical BCG for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169 (2003) 96
3. Holmang S., Hedelin H., Anderstrom H., and Johansson S.L. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153 (1995) 1823
4. Holmang S., Andius P., Hedelin H., and Johansson S.L. Stage progression in papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165 (2001) 1124
5. Millan-Rodriquez F., Chechile-Toniolo G., and Salvador-Bayarri J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000) 73
6. Konety B.R., and Williams R.D. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94 (2004) 18
7. Holmang S., and Johansson S.L. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167 (2002) 1634
8. Lee C.T., Montie J.E., and Zhang Y.X. Lymphovascular invasion is an independent predictor of survival in cT1 bladder cancer. J Urol, suppl 173 (2005) 246 abstract 911
9. Goddard J.C., Sutton C.D., Furness P.N., and O'Byrne K.J. Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer. Clin Cancer Res 9 (2003) 2583
10. Cheng L., Neumann R.M., Weaver A.L., Spotts B.E., and Bostwick D.G. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 17 (1999) 3182
11. Hitchings A.W., Kumar M., Jordan S., Nargund V., Martin J., and Berney D.M. Prediction of progression of pTa and pT1 bladder carcinomas with p53, p16 and pRb. Br J Cancer 91 (2004) 552
12. Blaveri E., Simko J.P., Korkola J.E., Brewer J.L., Baehner F., and Waldman F.M. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11 (2005) 4044
13. Dalbagni G, Parekh DJ, Ben-Porat L, Potenzoni M, Herr HW and Reuter VE: Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. Unpublished data.
14. Herr H.W., and Sogani P.C. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol 166 (2001) 1296
15. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74
16. Herr H.W. A restaging transurethral resection of high risk superficial bladder cancer improves the initial response to BCG therapy. J Urol 174 (2005) 2134
17. Dalbagni G., Herr H.W., and Reuter V.E. Impact of a second transurethral resection on staging of T1 bladder cancer. Urol 60 (2002) 822
18. Epstein J.I., Amin M.B., Reuter V.E., and Mostofi F.K. The World Health Organization-International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435
19. Badalament R.A., Herr H.W., Wong G.Y., Oettgen H.F., and Whitmore W.F. A randomized trial of maintenance versus nonmaintenance intravesical BCG therapy of superficial bladder cancer. J Clin Oncol 5 (1987) 441
20. Nieder A.M., Brausi M., Lamm D., O'Donnell M., Tomita K., Woo H., et al. Management of stage T1 tumors of the bladder: international consensus panel. Urology 66 suppl (2005) 108